U.S. market Closed. Opens in 2 days 6 hours 31 minutes

GCTK | GlucoTrack, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.2437 - 0.2677
52 Week Range 0.2160 - 4.95
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 505,065
Average Volume 305,437
Shares Outstanding 5,772,030
Market Cap 1,500,151
Sector Healthcare
Industry Medical - Instruments & Supplies
IPO Date 2013-04-25
Valuation
Profitability
Growth
Health
P/E Ratio -0.09
Forward P/E Ratio N/A
EPS -2.91
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 6
Country Israel
Website GCTK
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It also focuses on developing a wireless module for transmission of measurement data captured by the GlucoTrack model DF-F to a cloud-based server.
GCTK's peers: NXGL, AVGR, STSS, LUCY, GMVD, POAI, MBOT, PDEX, ZJYL, MHUA, BNGO, EKSO
*Chart delayed
Analyzing fundamentals for GCTK we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see GCTK Fundamentals page.

Watching at GCTK technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on GCTK Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙